Pharmanutra Statistics
Total Valuation
Pharmanutra has a market cap or net worth of EUR 483.04 million. The enterprise value is 478.22 million.
Market Cap | 483.04M |
Enterprise Value | 478.22M |
Important Dates
The last earnings date was Friday, March 14, 2025.
Earnings Date | Mar 14, 2025 |
Ex-Dividend Date | May 5, 2025 |
Share Statistics
Pharmanutra has 9.60 million shares outstanding. The number of shares has decreased by -0.61% in one year.
Current Share Class | n/a |
Shares Outstanding | 9.60M |
Shares Change (YoY) | -0.61% |
Shares Change (QoQ) | -0.27% |
Owned by Insiders (%) | 10.74% |
Owned by Institutions (%) | 15.73% |
Float | 4.26M |
Valuation Ratios
The trailing PE ratio is 29.10 and the forward PE ratio is 22.69.
PE Ratio | 29.10 |
Forward PE | 22.69 |
PS Ratio | 4.16 |
PB Ratio | 7.77 |
P/TBV Ratio | 11.82 |
P/FCF Ratio | 29.73 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.58, with an EV/FCF ratio of 29.43.
EV / Earnings | 28.79 |
EV / Sales | 4.12 |
EV / EBITDA | 15.58 |
EV / EBIT | 17.48 |
EV / FCF | 29.43 |
Financial Position
The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.39.
Current Ratio | 2.38 |
Quick Ratio | 1.95 |
Debt / Equity | 0.39 |
Debt / EBITDA | 0.79 |
Debt / FCF | 1.49 |
Interest Coverage | 25.76 |
Financial Efficiency
Return on equity (ROE) is 28.39% and return on invested capital (ROIC) is 20.25%.
Return on Equity (ROE) | 28.39% |
Return on Assets (ROA) | 14.88% |
Return on Invested Capital (ROIC) | 20.25% |
Return on Capital Employed (ROCE) | 30.36% |
Revenue Per Employee | 984,305 |
Profits Per Employee | 140,754 |
Employee Count | 118 |
Asset Turnover | 1.01 |
Inventory Turnover | 7.53 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.25% in the last 52 weeks. The beta is 0.32, so Pharmanutra's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | -13.25% |
50-Day Moving Average | 52.60 |
200-Day Moving Average | 52.74 |
Relative Strength Index (RSI) | 39.79 |
Average Volume (20 Days) | 15,814 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharmanutra had revenue of EUR 116.15 million and earned 16.61 million in profits. Earnings per share was 1.73.
Revenue | 116.15M |
Gross Profit | 59.24M |
Operating Income | 27.36M |
Pretax Income | 27.16M |
Net Income | 16.61M |
EBITDA | 30.24M |
EBIT | 27.36M |
Earnings Per Share (EPS) | 1.73 |
Balance Sheet
The company has 29.10 million in cash and 24.27 million in debt, giving a net cash position of 4.83 million or 0.50 per share.
Cash & Cash Equivalents | 29.10M |
Total Debt | 24.27M |
Net Cash | 4.83M |
Net Cash Per Share | 0.50 |
Equity (Book Value) | 62.20M |
Book Value Per Share | 6.48 |
Working Capital | 37.67M |
Cash Flow
In the last 12 months, operating cash flow was 20.50 million and capital expenditures -4.25 million, giving a free cash flow of 16.25 million.
Operating Cash Flow | 20.50M |
Capital Expenditures | -4.25M |
Free Cash Flow | 16.25M |
FCF Per Share | 1.69 |
Margins
Gross margin is 51.00%, with operating and profit margins of 23.56% and 14.30%.
Gross Margin | 51.00% |
Operating Margin | 23.56% |
Pretax Margin | 23.39% |
Profit Margin | 14.30% |
EBITDA Margin | 26.04% |
EBIT Margin | 23.56% |
FCF Margin | 13.99% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.01%.
Dividend Per Share | 1.00 |
Dividend Yield | 2.01% |
Dividend Growth (YoY) | 17.65% |
Years of Dividend Growth | 4 |
Payout Ratio | 49.20% |
Buyback Yield | 0.61% |
Shareholder Yield | 2.62% |
Earnings Yield | 3.44% |
FCF Yield | 3.36% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Pharmanutra has an Altman Z-Score of 7.99.
Altman Z-Score | 7.99 |
Piotroski F-Score | n/a |